For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Corvas International, Inc.

USPTO Granted Patents = 75

Forward Citations = 672

Loading Chart...

Loading Chart...

50 inventors (with patents filed for the assignee):

George Phillip Vlasuk (28 out of 31 patents)

Joseph Edward Semple (20 out of 30 patents)

Matthew Moyle (19 out of 20 patents)

4. Terence Kevin Brunck (19 out of 21 patents)

5. William Charles Ripka (17 out of 27 patents)

6. Matthew M Abelman (16 out of 18 patents)

7. Yves Rene LaRoche (15 out of 15 patents)

8. Laurent Stephane Jespers (15 out of 17 patents)

9. Ruth F Nutt (15 out of 47 patents)

10. Thomas R Webb (15 out of 21 patents)

11. Peter W Bergum (13 out of 13 patents)

12. Patrick Eric Stanssens (13 out of 13 patents)

13. Joris Hilda Messens (13 out of 13 patents)

14. Robert J Ardecky (12 out of 32 patents)

15. Susan Yoshiko Tamura (12 out of 12 patents)

Core Competencies:

Serine Protease Inhibitors

Anticoagulant Proteins

Thrombin Inhibitors

Neutrophil Inhibitors

Urokinase Inhibitors

Enzyme Inhibitors

Blood Coagulation

Factor Xa Inhibitors

Aromatic Heterocyclic Derivatives

Plasminogen Activator Inhibitors

Thrombosis Inhibitors

Hydrazinyl Heteroaromatic Inhibitors

75 patents: Sort by Forward Citations

1. 6872808 - Nematode-extracted serine protease inhibitors and anticoagulant proteins (2005-03-29),

2. 6818616 - Neutrophil inhibitors (2004-11-16),

3. 6777431 - Non-convalent thrombin inhibitors (2004-08-17),

4. 6756211 - Neutropohil inhibitors (2004-06-29),

5. 6677473 - Plasminogen activator inhibitor antagonists (2004-01-13),

6. 6638977 - Plasminogen activator inhibitor antagonists (2003-10-28),

7. 6608204 - Aromatic heterocyclic derivatives as enzyme inhibitors (2003-08-19),

8. 6586405 - Non-covalent inhibitors of urokinase and blood vessel formation (2003-07-01),

9. 6576613 - Title inhibitors of urokinase (2003-06-10),

10. 6541467 - Thrombin inhibitors having a lactam at P3 (2003-04-01),

11. 6534629 - Nematode-extracted serine protease inhibitors and anticoagulant proteins (2003-03-18),

12. 6506761 - Substituted hydrazinyl heteroaromatic inhibitors of thrombin (2003-01-14),

13. 6506760 - Substituted hydrazinyl heteroaromatic inhibitors of thrombin (2003-01-14),

14. 6506754 - Non-covalent thrombin inhibitors (2003-01-14),

15. 6432922 - Inhibitors of urokinase and blood vessel formation (2002-08-13),

Corvas International, Inc. is a global technology company specializing in cutting-edge solutions for various industries. With a strong focus on innovation and sustainability, we strive to deliver efficient and reliable products and services. Our diverse portfolio includes advanced software development, engineering solutions, and consultancy services. We collaborate with clients worldwide, helping them to optimize processes, enhance productivity, and drive growth. Visit our website for more information and to explore our range of solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

75 Patents

#81 in San Diego, CA

#1,129 in California

#4,709 in US

#9,625 in the World

San Diego, CA, United States of America

Corvas International, Inc.

Forward Citations = 672

50 inventors:

George Phillip Vlasuk (28 out of 31 patents)

Joseph Edward Semple (20 out of 30 patents)

Matthew Moyle (19 out of 20 patents)

4. Terence Kevin Brunck (19 out of 21 patents)

5. William Charles Ripka (17 out of 27 patents)

Please report any incorrect information to support@idiyas.com

Loading…